Claudia Omarini
8PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 27, 2025
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments.Lorenzo Belluzzi, Giulio Martinelli, Bianca Medici
|Jun 07, 2022
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis.Claudia Omarini, Federico Piacentini, Isabella Sperduti
|May 15, 2020
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials.Claudia Omarini, Federico Piacentini, Isabella Sperduti
|Feb 04, 2020
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.Claudia Omarini, Patrizia Palumbo, Annarita Pecchi
|Jan 04, 2019
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status.Claudia Omarini, Stefania Bettelli, Cecilia Caprera
|Nov 08, 2018
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.Teresa Gamucci, Laura Pizzuti, Clara Natoli
Pageof 2
